BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24929205)

  • 1. Clinical relevance of urinary angiotensinogen and renin as potential biomarkers in patients with overt proteinuria.
    Jang HR; Jeon J; Park JH; Lee JE; Huh W; Oh HY; Kim YG
    Transl Res; 2014 Nov; 164(5):400-10. PubMed ID: 24929205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The origin and the clinical significance of urinary angiotensinogen in proteinuric IgA nephropathy patients.
    Jang HR; Kim SM; Lee YJ; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
    Ann Med; 2012 Aug; 44(5):448-57. PubMed ID: 21366514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary angiotensinogen as a surrogate marker predicting the antiproteinuric effects of angiotensin receptor blockers in patients with overt proteinuria: a multicenter prospective study.
    Jeon J; Kim DH; Jang HR; Lee JE; Huh W; Kim HY; Kim DJ; Kim YG
    BMC Nephrol; 2020 May; 21(1):180. PubMed ID: 32410703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intrarenal renin-angiotensin system activity in diabetic versus non-diabetic patients with overt proteinuria.
    Park JH; Jang HR; Lee JH; Lee JE; Huh W; Lee KB; Kwon YJ; Do JY; Kim HY; Kim YG
    Nephrology (Carlton); 2015 Apr; 20(4):279-85. PubMed ID: 25522682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of urinary angiotensinogen in predicting antiproteinuric effects of angiotensin receptor blocker in non-diabetic chronic kidney disease patients: a preliminary report.
    Jang HR; Lee YJ; Kim SR; Kim SG; Jang EH; Lee JE; Huh W; Kim YG
    Postgrad Med J; 2012 Apr; 88(1038):210-6. PubMed ID: 22357774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
    Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
    BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary angiotensinogen level is correlated with proteinuria in renal transplant recipients.
    Erdogmus S; Sengul S; Kocak S; Kurultak I; Celebi ZK; Kutlay S; Keven K; Erbay B; Erturk S
    Transplant Proc; 2013 Apr; 45(3):935-9. PubMed ID: 23622592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
    Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
    J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.
    Xu Z; Xu B; Xu C
    Ir J Med Sci; 2015 Jun; 184(2):297-304. PubMed ID: 24664631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.
    Lee MJ; Kim SS; Kim IJ; Song SH; Kim EH; Seo JY; Kim JH; Kim S; Jeon YK; Kim BH; Kim YK
    J Korean Med Sci; 2017 May; 32(5):782-788. PubMed ID: 28378551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients?
    Aybal Kutlugun A; Altun B; Buyukasik Y; Aki T; Turkmen E; Altindal M; Yildirim T; Yilmaz R; Turgan C
    Transpl Int; 2012 Jan; 25(1):13-8. PubMed ID: 21923802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of urinary angiotensinogen in renal transplant recipients.
    Naganuma T; Takemoto Y; Maeda S; Maeda Y; Kuwabara N; Uchida J; Nakatani T
    Transplant Proc; 2014; 46(2):489-91. PubMed ID: 24655996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.
    Ohashi N; Yamamoto T; Huang Y; Misaki T; Fukasawa H; Suzuki H; Togawa A; Suzuki S; Fujigaki Y; Nakagawa T; Nakamura Y; Suzuki F; Kitagawa M; Hishida A
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1512-8. PubMed ID: 18784264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.
    Zhang XY; Ding XQ; Lv WL; Teng J; Zhong YH
    Mol Biol Rep; 2013 Oct; 40(10):5817-24. PubMed ID: 24065527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients.
    Kutlugün AA; Altun B; Aktan U; Turkmen E; Altindal M; Yildirim T; Yilmaz R; Arici M; Erdem Y; Turgan C
    Amyloid; 2012 Mar; 19(1):28-32. PubMed ID: 22320202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules.
    Ohashi N; Aoki T; Matsuyama T; Ishigaki S; Isobe S; Katahashi N; Sato T; Fujikura T; Kato A; Yasuda H
    Intern Med; 2020 Feb; 59(3):357-364. PubMed ID: 31534091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricaemia is associated with renal damage independently of hypertension and intrarenal renin-angiotensin system activation, as well as their circadian rhythms.
    Ohashi N; Ishigaki S; Isobe S; Tsuji N; Iwakura T; Ono M; Tsuji T; Sakao Y; Kato A; Yasuda H
    Nephrology (Carlton); 2015 Nov; 20(11):814-9. PubMed ID: 25968901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
    Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H
    Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function.
    Matsuyama T; Ohashi N; Ishigaki S; Isobe S; Tsuji N; Fujikura T; Tsuji T; Kato A; Miyajima H; Yasuda H
    Intern Med; 2018 Nov; 57(22):3241-3247. PubMed ID: 29984779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary renin-angiotensin markers in polycystic kidney disease.
    Salih M; Bovée DM; Roksnoer LCW; Casteleijn NF; Bakker SJL; Gansevoort RT; Zietse R; Danser AHJ; Hoorn EJ
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F874-F881. PubMed ID: 28747358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.